183 related articles for article (PubMed ID: 30696421)
1. The active role of the transcription factor Sp1 in NFATc2-mediated gene regulation in pancreatic cancer.
Malsy M; Graf B; Almstedt K
BMC Biochem; 2019 Jan; 20(1):2. PubMed ID: 30696421
[TBL] [Abstract][Full Text] [Related]
2. Interaction between NFATc2 and the transcription factor Sp1 in pancreatic carcinoma cells PaTu 8988t.
Malsy M; Graf B; Almstedt K
BMC Mol Biol; 2017 Aug; 18(1):20. PubMed ID: 28774282
[TBL] [Abstract][Full Text] [Related]
3. Effect of NFATc2- and Sp1-mediated TNFalpha Regulation on the Proliferation and Migration Behavior of Pancreatic Cancer Cells.
Malsy M; Graf B; Bruendl E; Maier-Stocker C; Bundscherer A
Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):706-711. PubMed ID: 38035702
[TBL] [Abstract][Full Text] [Related]
4. The Effects of Analgesics and Local Anesthetics on Gene Transcription Mediated by NFATc2 and Sp1 in Pancreatic Carcinoma.
Malsy M; Graf B; Bundscherer A
Anticancer Res; 2019 Sep; 39(9):4721-4728. PubMed ID: 31519571
[TBL] [Abstract][Full Text] [Related]
5. Over-expression of cFos by the Transcription Factors NFATc2 and Sp1 in Pancreatic Cancer Cells.
Malsy M; Graf B; Bruendl E; Maier-Stocker C; Bundscherer A
Anticancer Res; 2023 Nov; 43(11):4897-4904. PubMed ID: 37909980
[TBL] [Abstract][Full Text] [Related]
6. GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression.
Baumgart S; Chen NM; Zhang JS; Billadeau DD; Gaisina IN; Kozikowski AP; Singh SK; Fink D; Ströbel P; Klindt C; Zhang L; Bamlet WR; Koenig A; Hessmann E; Gress TM; Ellenrieder V; Neesse A
Mol Cancer Ther; 2016 Mar; 15(3):491-502. PubMed ID: 26823495
[TBL] [Abstract][Full Text] [Related]
7. The LIM protein Ajuba/SP1 complex forms a feed forward loop to induce SP1 target genes and promote pancreatic cancer cell proliferation.
Zhang B; Song L; Cai J; Li L; Xu H; Li M; Wang J; Shi M; Chen H; Jia H; Hou Z
J Exp Clin Cancer Res; 2019 May; 38(1):205. PubMed ID: 31101117
[TBL] [Abstract][Full Text] [Related]
8. Restricted heterochromatin formation links NFATc2 repressor activity with growth promotion in pancreatic cancer.
Baumgart S; Glesel E; Singh G; Chen NM; Reutlinger K; Zhang J; Billadeau DD; Fernandez-Zapico ME; Gress TM; Singh SK; Ellenrieder V
Gastroenterology; 2012 Feb; 142(2):388-98.e1-7. PubMed ID: 22079596
[TBL] [Abstract][Full Text] [Related]
9. Smad-Sp1 complexes mediate TGFbeta-induced early transcription of oncogenic Smad7 in pancreatic cancer cells.
Jungert K; Buck A; Buchholz M; Wagner M; Adler G; Gress TM; Ellenrieder V
Carcinogenesis; 2006 Dec; 27(12):2392-401. PubMed ID: 16714330
[TBL] [Abstract][Full Text] [Related]
10. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
Zhao S; Venkatasubbarao K; Li S; Freeman JW
Cancer Res; 2003 May; 63(10):2624-30. PubMed ID: 12750289
[TBL] [Abstract][Full Text] [Related]
11. Mitofusin-2 (Mfn-2) Might Have Anti-Cancer Effect through Interaction with Transcriptional Factor SP1 and Consequent Regulation on Phosphatidylinositol Transfer Protein 3 (PITPNM3) Expression.
Tang T; Tao X; Bao X; Chen J; Dai J; Ye J; Yan Y
Med Sci Monit; 2020 Jan; 26():e918599. PubMed ID: 31955176
[TBL] [Abstract][Full Text] [Related]
12. Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma.
Shi Q; Le X; Abbruzzese JL; Peng Z; Qian CN; Tang H; Xiong Q; Wang B; Li XC; Xie K
Cancer Res; 2001 May; 61(10):4143-54. PubMed ID: 11358838
[TBL] [Abstract][Full Text] [Related]
13. Sp1-mediated transcriptional regulation of MALAT1 plays a critical role in tumor.
Li S; Wang Q; Qiang Q; Shan H; Shi M; Chen B; Zhao S; Yuan L
J Cancer Res Clin Oncol; 2015 Nov; 141(11):1909-20. PubMed ID: 25773124
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor Sp1 is upregulated by PKCι to drive the expression of YAP1 during pancreatic carcinogenesis.
Yang J; Wang J; Zhang H; Li C; Chen C; Zhu T
Carcinogenesis; 2021 Apr; 42(3):344-356. PubMed ID: 33146712
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity.
Wei D; Wang L; He Y; Xiong HQ; Abbruzzese JL; Xie K
Cancer Res; 2004 Mar; 64(6):2030-8. PubMed ID: 15026340
[TBL] [Abstract][Full Text] [Related]
16. Cot/Tpl2 and PKCzeta cooperate in the regulation of the transcriptional activity of NFATc2 through the phosphorylation of its amino-terminal domain.
Gómez-Casero E; San-Antonio B; Iñiguez MA; Fresno M
Cell Signal; 2007 Aug; 19(8):1652-61. PubMed ID: 17398070
[TBL] [Abstract][Full Text] [Related]
17. Differential contribution of NFATc2 and NFATc1 to TNF-alpha gene expression in T cells.
Kaminuma O; Kitamura F; Kitamura N; Hiroi T; Miyoshi H; Miyawaki A; Miyatake S
J Immunol; 2008 Jan; 180(1):319-26. PubMed ID: 18097033
[TBL] [Abstract][Full Text] [Related]
18. Reversion of transcriptional repression of Sp1 by 5 aza-2' deoxycytidine restores TGF-beta type II receptor expression in the pancreatic cancer cell line MIA PaCa-2.
Venkatasubbarao K; Ammanamanchi S; Brattain MG; Mimari D; Freeman JW
Cancer Res; 2001 Aug; 61(16):6239-47. PubMed ID: 11507078
[TBL] [Abstract][Full Text] [Related]
19. WNT5A-NFAT signaling mediates resistance to apoptosis in pancreatic cancer.
Griesmann H; Ripka S; Pralle M; Ellenrieder V; Baumgart S; Buchholz M; Pilarsky C; Aust D; Gress TM; Michl P
Neoplasia; 2013 Jan; 15(1):11-22. PubMed ID: 23359789
[TBL] [Abstract][Full Text] [Related]
20. CpG methylation and transcription factors Sp1 and Sp3 regulate the expression of the human secretin receptor gene.
Pang RT; Lee LT; Ng SS; Yung WH; Chow BK
Mol Endocrinol; 2004 Feb; 18(2):471-83. PubMed ID: 14645499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
